Here are the main points for the quarter ending 30 June 2018
- Uptake rates by 12 months of age increased slightly and remain above 95% for complete primary courses of immunisation of Pneumococcal Conjugate Vaccine (PCV), MenB vaccine, and the five-in-one vaccine, which protects against: diphtheria, tetanus, pertussis (whooping cough), polio and Haemophilus (Hib).
- Uptake of the complete two dose course of rotavirus vaccine by 12 months of age remained at 93.5%.
- Uptake rates of the Hib/MenC and PCV booster vaccines by 24 months both increased slightly, with rates at 95.1% and 95.3% respectively.
- The national target is for 95% uptake of one dose of the MMR vaccine by five years of age, with a supplementary measure at 24 months. Uptake of one dose of MMR vaccine increased slightly to94.5% by 24 months of age and 96.9% by five years of age. Uptake rates of one dose of MMR by five years have remained above the 95% target since 2009.